On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 - ScienceDirect
The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein | eLife
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV | bioRxiv
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine - eBioMedicine
Vaccines | Free Full-Text | Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
JCI - Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
The antigenic anatomy of SARS-CoV-2 receptor binding domain - Instruct-ERIC
Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus | Journal of Virology
SARS-CoV-2 spike protein antibody | Abcam
Monoclonal antibody designed for SARS-nCoV-2 spike protein of receptor binding domain on antigenic targeted epitopes for inhibition to prevent viral entry | Molecular Diversity
Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication | PLOS ONE
Durable SARS-CoV-2 B cell immunity after mild or severe disease | medRxiv
Frontiers | A SARS–CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients
Human neutralizing monoclonal antibody IgG1 (Clone P5E1) anti-RBD (Receptor Binding Domain) of SARS-CoV-2, Wuhan and Delta (KD = 27 nM, BIAcore) - UDIBI
Covalent coupling of Spike's receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2 | Scientific Reports
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications
Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain | ACS Omega
The receptor binding domain of the SARS-CoV-2
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2 | PNAS
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV | Science
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies - ScienceDirect
Human Antibodies Target Many Parts of Coronavirus Spike Protein – NIH Director's Blog
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition - ScienceDirect
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature
Anti-Receptor binding domain (RBD) total antibodies 1 month after the... | Download Scientific Diagram
Human IgM SARS-CoV-2 Antibody (DH6) - The Native Antigen Company
